Evidence map›Paper›PMID 41229522›Full record

ArticleFrontiers in medicine2025

Macular morphology after cataract surgery with and without primary posterior continuous curvilinear capsulorhexis.

Chishan Kang, Kunxia Lin, Yulong Huang, Mengting Yu, Wenjie Wu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chishan Kang *Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.
Kunxia Lin *Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.
Yulong HuangShengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.
Mengting YuShengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.
Wenjie WuShengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate changes in macular morphology after cataract surgery with and without primary posterior continuous curvilinear capsulorhexis (PPCCC). Methods: A prospective, intraindividual, randomized clinical trial was performed at Fuzhou University Affiliated Provincial Hospital, Fujian, China. A total of 130 eyes of 65 age-related cataract patients with normal macular morphology and function waiting for bilateral cataract surgery and intraocular lens (IOL) implantation were enrolled. Cataract surgery combined with PPCCC was performed in one eye, and routine cataract surgery in the fellow eye (NPCCC group). Optical coherence tomography (OCT) measurements were performed in all patients preoperatively and postoperatively on 1 day, 1 week, 1 month, and 3 months. Results: A total of 120 eyes of 60 patients were capable to complete scheduled follow-ups and analyzed in the study. There was no statistically significant difference between the PPCCC group and NPCCC group in terms of subfoveal central retinal thickness (CRT), central 1-mm subfield (CSF), average retinal thickness in the middle (1-3 mm) and outer (3-6 mm) rings ( Conclusion: Cataract surgery with combined manual PPCCC does not increase the risk of CME and PVD in patients. PPCCC is a safe cataract surgery technique.

Indexed as

cataract surgerycystoid macular edemaposterior capsulorhexisposterior vitreous detachment (PVD)surgery technique

Identifiers

PMID41229522
PMCPMC12602534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.